Definitive Contract W911NF23C0002
Award Date
12/15/22
Potential Completion Date
2/29/24
Potential Value
$4.8M
Funding Federal Agency
Defense Advanced Research Projects Agency
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Ginkgo Bioworks, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Cost Plus Fixed Fee contract awarded by the Navy NAVSUP Engineering Logistics Office to Ginkgo Bioworks, Inc., a Boston-based biotechnology company, for the IARPA FELIX PROGRAM. The contract has a ceiling value of $5,338,550.00 and a completion date of June 30, 2022. Ginkgo Bioworks is a for-profit manufacturer of goods that specializes in cellular engineering, DNA sequencing, and advanced biological manufacturing services. The company has a proven track record of delivering complex...
This is a $3,999,210.00 cost-plus-fixed-fee definitive contract awarded by the Department of the Navy Information Warfare Systems Command to Ginkgo Bioworks, Inc., a biotechnology firm based in Boston, for the DNA Recording Intrinsic Cellular Biointelligence (DRINC BIO) project. The contract has a completion date of May 21, 2025 and was awarded on May 2, 2023 with no set-aside designation. Ginkgo Bioworks provides research, testing, and production services related to cellular engineering, DNA...
This is a $14,605,403.00 cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a Boston-based biotechnology company. The contract is part of DARPA's ReVector program, which aims to develop methods to use human skin microbiomes to modulate chemical production in order to avoid mosquito attraction and feeding, thereby reducing the threat of mosquito-borne disease to U.S. military personnel. The original solicitation, with...
This is a $12,045,252.00 cost-plus-fixed-fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a Boston-based biotechnology company. The contract is for the "ICE CONTROL FOR COLD ENVIRONMENTS (ICE)" program, which seeks to develop biologically-sourced or inspired molecules to inhibit ice crystallization, propagation, and adhesion to mitigate extreme cold weather challenges for Department of Defense (DoD) applications. The original...
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
This is a $5,632,809.00 Cost Plus Fixed Fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Leidos, Inc. (Leidos) to develop technologies that enable immediate synthesis of bioactive protein medical countermeasures and production enzymes within 24 hours at a yield of at least 500 doses per week. The contract is part of DARPA's Reimagining Protein Manufacturing (RPM) program, which aims to establish foundational technologies for distributed, on-demand manufacturing of...
This federal contract award, valued at $31,863,305.85, is for the DARPA "Living Foundries: 1000 Molecules" program, which aims to build a scalable, integrated, rapid design and prototyping infrastructure for engineering biology. The prime contractor is the Massachusetts Institute of Technology (MIT), a premier private research university. The contract has no set-aside designation and is a definitive contract with a cost-no-fee pricing type. Major subcontractors include the Broad...
This federal contract award is for the Bio-Mod program, which seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. The prime contractor is the Massachusetts Institute of Technology (MIT), a premier private research university known for its advanced scientific and technological capabilities. The $24,851,563.00 contract does not have a set-aside designation, indicating MIT's broad competitiveness across...
This is a $149,661.75 firm-fixed-price Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer. The contract is for the development of a next-generation cell-free prototyping and biomanufacturing platform. Biodiscovery LLC, a subsidiary of the Japanese chemical company Daicel Corporation, specializes in custom molecular...
The National Institutes of Health's National Heart, Lung and Blood Institute awarded Ginkgo Bioworks, Inc. a $6.57 million firm fixed price definitive contract to support the Rapid Acceleration of Diagnostics-Advanced Technology Platforms program. The goal of this program is to increase SARS-CoV-2 testing capacity and throughput by identifying existing testing platforms that can be used for COVID-19 diagnostics. Work will be performed by Ginkgo Bioworks in Boston, Massachusetts over a one year...